CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 152 enrolled
Drug / intervention
no interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01856569
NCT01856569N/ACompleted

Assial - Anti Tnf Treatment In Ankylosing Spondylitis: An Observational Cohort Study In Italy

Pfizer·observational·Posted May 17, 2013·Updated Mar 9, 2017

In Brief

An observational study evaluating no intervention for Ankylosing Spondylitis. Completed, enrolled 152 participants across 18 sites.

Detailed Summary

Observe in real life adherence therapy and time to switch in ankylosing spondylitis patients with predominant assial involvement with 4 anti-TNF.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 17, 2013
Enrollment StartJul 1, 2013
Primary CompletionOct 1, 2015
Study CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.1 years ago

Interventions

no interventionother

in real life of drug,dosage,frequency and duration